- Home
- ABUS vs NTGR Comparison
ABUS vs NTGR Comparison
Compare ABUS & NTGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABUS
- NTGR
- Stock Information
- Founded
- ABUS 2005
- NTGR 1996
- Country
- ABUS United States
- NTGR United States
- Employees
- ABUS N/A
- NTGR N/A
- Industry
- ABUS Biotechnology: Pharmaceutical Preparations
- NTGR Telecommunications Equipment
- Sector
- ABUS Health Care
- NTGR Utilities
- Exchange
- ABUS Nasdaq
- NTGR Nasdaq
- Market Cap
- ABUS 711.2M
- NTGR 776.6M
- IPO Year
- ABUS N/A
- NTGR N/A
- Fundamental
- Price
- ABUS $4.20
- NTGR $27.95
- Analyst Decision
- ABUS Strong Buy
- NTGR Strong Buy
- Analyst Count
- ABUS 3
- NTGR 2
- Target Price
- ABUS $5.67
- NTGR $32.00
- AVG Volume (30 Days)
- ABUS 1.0M
- NTGR 405.8K
- Earning Date
- ABUS 11-05-2025
- NTGR 10-29-2025
- Dividend Yield
- ABUS N/A
- NTGR N/A
- EPS Growth
- ABUS N/A
- NTGR N/A
- EPS
- ABUS N/A
- NTGR 2.16
- Revenue
- ABUS $15,416,000.00
- NTGR $697,865,000.00
- Revenue This Year
- ABUS $138.02
- NTGR $4.83
- Revenue Next Year
- ABUS N/A
- NTGR $3.86
- P/E Ratio
- ABUS N/A
- NTGR $12.92
- Revenue Growth
- ABUS 53.23
- NTGR 0.41
- 52 Week Low
- ABUS $2.71
- NTGR $15.40
- 52 Week High
- ABUS $4.73
- NTGR $31.55
- Technical
- Relative Strength Index (RSI)
- ABUS 84.85
- NTGR 62.44
- Support Level
- ABUS $3.60
- NTGR $26.28
- Resistance Level
- ABUS $4.10
- NTGR $27.28
- Average True Range (ATR)
- ABUS 0.17
- NTGR 0.80
- MACD
- ABUS 0.06
- NTGR 0.32
- Stochastic Oscillator
- ABUS 83.33
- NTGR 85.88
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.
About NTGR NETGEAR Inc.
Netgear Inc provider of networking technologies for businesses, homes, and service providers. It delivers a wide range of intelligent solutions designed to unleash the full potential of connectivity. The group has two segments: NETGEAR for Business and Connected Home which offers reliable, easy-to-use, high-performance networking solutions, including switches, routers, access points, software, and AV over IP technologies, tailored to meet the diverse needs of organizations of all sizes. The Connected Home segment offers connectivity, powerful performance, and enhanced security features right out of the box, designed to help keep families safe online, and Others. It conduct business across three geographic territories: Americas; Europe, Middle East and Africa; and Asia Pacific.